Intrinsic Value of S&P & Nasdaq Contact Us

inTEST Corporation INTT NYSE

NYSE • Technology • Semiconductors • US • USD

SharesGrow Score
40/100
1/7 Pass
SharesGrow Intrinsic Value
$43.96
+185.3%
Analyst Price Target
$11.33
-26.5%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

inTEST Corporation (INTT) has a negative trailing P/E of -75.1, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 37.0 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -1.33%, forward earnings yield 2.70%. PEG 1.28.

Criteria proven by this page:

  • VALUE (10/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -75.1); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -1.33%); analyst consensus target implies downside from the current price ($11.33, 26.5%).
  • Forward P/E 37.0 — analysts expect a return to profitability with estimated EPS of $0.42 for FY2026.
  • PEG Ratio 1.28 — between 1.0–2.0 indicates moderate valuation relative to growth.
  • Trailing Earnings Yield -1.33% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 2.70% as earnings recover.
  • Analyst consensus target $11.33 (-26.5% downside) — analysts see meaningful downside risk at the current price level.

Overall SharesGrow Score: 40/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
40/100
SG Score
View full scorecard →
VALUE
10/100
Price-to-Earnings & upside
Proven by this page
FUTURE
64/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
~
HEALTH
67/100
Debt-to-Equity & liquidity
→ Health
MOAT
42/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — INTT

Valuation Multiples
P/E (TTM)-75.1
Forward P/E37.0
PEG Ratio1.28
Forward PEG1.28
P/B Ratio1.83
P/S Ratio1.70
EV/EBITDA63.5
Per Share Data
EPS (TTM)$-0.21
Forward EPS (Est.)$0.42
Book Value / Share$8.48
Revenue / Share$9.32
FCF / Share$0.47
Yields & Fair Value
Earnings Yield-1.33%
Forward Earnings Yield2.70%
Dividend Yield0.00%
SharesGrow IV$43.96 (+185.3%)
Analyst Target$11.33 (-26.5%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 17.8 0.40 1.26 1.18 -
2017 91.2 -1.40 2.26 1.33 -
2018 20.9 0.09 1.48 0.81 -
2019 26.6 -1.10 1.38 1.02 -
2020 -74.4 0.53 1.49 1.24 -
2021 18.3 -0.02 2.43 1.57 -
2022 13.0 1.01 1.69 0.94 -
2023 16.7 4.39 1.62 1.26 -
2024 36.1 -0.51 1.05 0.80 -
2025 -36.1 0.19 0.88 0.80 -

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $0.26 $40.23M $2.66M 6.6%
2017 $0.09 $66.8M $975K 1.5%
2018 $0.29 $78.56M $3.04M 3.9%
2019 $0.22 $60.66M $2.32M 3.8%
2020 $-0.09 $53.82M $-895K -1.7%
2021 $0.68 $84.88M $7.28M 8.6%
2022 $0.78 $116.83M $8.46M 7.2%
2023 $0.79 $123.3M $9.34M 7.6%
2024 $0.24 $130.69M $2.89M 2.2%
2025 $-0.21 $113.83M $-2.53M -2.2%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $0.42 $0.41 – $0.42 $129.25M $128.05M – $130.75M 2
2027 $0.62 $0.62 – $0.63 $141.01M $139.69M – $142.64M 2
2028 $0.73 $0.72 – $0.74 $148.78M $147.39M – $150.5M 1
2029 $0.89 $0.88 – $0.90 $158.89M $157.41M – $160.73M 1
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message